OBESE
Clinical trials for OBESE explained in plain language.
Never miss a new study
Get alerted when new OBESE trials appear
Sign up with your email to follow new studies for OBESE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New obesity drug HM15275 shows promise in Mid-Stage trial
Disease control OngoingThis study tests a new medicine called HM15275 to help people with obesity or overweight lose weight. About 267 adults without diabetes will receive either the drug or a placebo for 36 weeks. The main goal is to see how much weight changes from the start to the end of treatment.
Matched conditions: OBESE
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New pill shows promise for diabetes and weight loss in early trial
Disease control OngoingThis study tests a new medication called aleniglipron in adults with type 2 diabetes who are also overweight or obese. The main goal is to see if the drug is safe and tolerable at different doses. Researchers will also check if it helps with weight loss and blood sugar control. A…
Matched conditions: OBESE
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Lifestyle changes may rewire sperm DNA, study suggests
Knowledge-focused OngoingThis study looks at how diet and exercise affect the epigenome (chemical tags on DNA) in sperm of overweight, inactive Hispanic men. Researchers compare sperm from healthy active men and obese inactive men, then track changes after 12 weeks of diet, exercise, or both. The goal is…
Matched conditions: OBESE
Phase: NA • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:06 UTC
-
Olive oil showdown: which kind boosts heart health?
Knowledge-focused OngoingThis study looks at how two different kinds of olive oil affect heart disease risk factors. Researchers will measure changes in cholesterol, inflammation, and gene activity in 44 healthy adults of various weights. The goal is to see if olive oil polyphenols can improve cardiovasc…
Matched conditions: OBESE
Phase: NA • Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated May 17, 2026 05:04 UTC
-
Does breakfast boost your child's brainpower? new study investigates.
Knowledge-focused OngoingThis study looks at how eating breakfast affects thinking and brain activity in 9-10 year old children who are obese. About 150 kids will take tests and have brain scans to measure their cognitive function. The goal is to understand the link between morning nutrition and brain pe…
Matched conditions: OBESE
Phase: NA • Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Could a diabetes drug shield the brain? early trial targets cognitive decline
Knowledge-focused TerminatedThis early-phase study looks at whether liraglutide (Saxenda®), a drug used for weight loss, can increase a brain-protective protein called BDNF in people with multiple sclerosis, long-COVID, or acute leukemia (in remission) who also have obesity and memory or thinking problems. …
Matched conditions: OBESE
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Gut sugar test may forecast surgery success
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if how the small intestine absorbs sugar can predict how much weight people lose after bariatric surgery. Researchers will compare obese patients scheduled for surgery with lean individuals. They will also check for gene changes that might affect sugar abso…
Matched conditions: OBESE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC